Venkat, who works as an ER physician, says dropping GLP-1 coverage for obesity only moves the cost to pricier medical problems later.
Recap by typeshit. Post by Facebook on Facebook.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
The festival is promoting a talk by Dr. Kenny Duggal, M.D., on how people taking GLP-1 drugs can lose weight while holding onto strength.
Lembke, a Stanford Medicine psychiatrist, weighs whether drugs like Ozempic could help treat addiction. The full Stanford story goes deeper into her view.
Loading…